Predictors of early graft patency following coronary artery bypass surgery

Cardiology Journal

Volumn 17, Issue 4, 2010, Pages 344-348

  Bassiri, Hossein Ali ^a   Salari, Farzad ^a   Noohi, Fereidoun ^a   Motevali, Marzieh ^a   Abdi, Seifollah ^a   Givtaj, Nader ^a   Raissi, Kamal ^a   Haghjoo, Majid ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary artery bypass grafting; Early patency; Predictor

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; GLUCOSE; INSULIN; NITRATE;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT OCCLUSION; GRAFT PATENCY; HUMAN; HYPERTENSION; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD;

AGED; BLOOD GLUCOSE; CARDIOPULMONARY BYPASS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; IRAN; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 77954992113     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Tan ES, van der Meer J, Jan de Kam P et al. Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women. CABADAS. Research Group of the Interuniversity Cardiology Institute of The Netherlands. Coronary Artery Bypass graft occlusion by Aspirin, Dipyridamole and Acenocoumarol/phenoprocoumon Study. J Am Coll Cardiol, 1999; 34: 1760-1768.
2. Goldman S, Zadina K, Moritz T et al.; VA Cooperative Study Group. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: Results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol, 2004; 44: 2149-2156.
3. Goldman S, Zadina K, Krasnicka B et al. Predictors of graft patency 3 years after coronary artery bypass graft surgery. Department of Veterans Affairs Cooperative Study Group. J Am Coll Cardiol, 1997; 29: 1563-1568.
4. Magee MJ, Dewey TM, Acuff T et al. Influence of diabetes on mortality and morbidity: off-pump coronary artery bypass grafting versus coronary artery bypass grafting with cardiopulmonary bypass. Ann Thorac Surg, 2001; 72: 776-781.
5. Calafiore AM, Di Mauro M, Di Giammarco G et al. Effects of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg, 2003; 125: 144-154.
6. Szabó Z, Håkanson E, Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2,239 non-diabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg, 2002; 74: 712-719.
7. McKay CR, Brundage BH, Ullyot DJ, Turley K, Lipton MJ, Ebert PA. Evaluation of early postoperative coronary artery bypass graft patency by contrast-enhanced computed tomography. J Am Coll Cardiol, 1983; 2: 312-317.
8. The BARI Investigators. Influence of diabetes on five-year mortality and morbidity in a randomized trial comparing PTCA and CABG in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI). Circulation, 1997; 96: 1761-1769.
9. Nashef SA, Roques F, Michel P et al. Coronary surgery in Europe: Comparison of the national subsets of the European system for cardiac operative risk evaluation database. Eur J Cardiothorac Surg, 2000; 17: 396-399.
10. Choi JS, Cho KR, Kim KB. Does diabetes affect the postoperative outcomes after total arterial off-pump coronary bypass surgery in multivessel disease? Ann Thorac Surg, 2005; 80: 1353-1360.
11. Boden G, Vaidyula VR, Homko C, Cheung P, Rao AK. Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: Effects of insulin and glucose. J Clin Endocrinol Metab, 2007; 92: 4352-4358.
12. Goldman S, Copeland J, Moritz T et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: Results of a Veterans Administration Cooperative Study. Circulation, 1988; 77: 1324-1332.
13. Goldman S, Copeland J, Moritz T et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy: Results of a Veterans Administration Cooperative Study. Circulation, 1989; 80: 1190-1197.
14. Lorenz RL, Schacky CV, Weber M et al. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily): Effects on platelet aggregation and thromboxane formation. Lancet, 1984; 1: 1261-1264.
15. Pantely GA, Goodnight SH Jr, Rahimtoola SH et al. Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study. N Engl J Med, 1979; 301: 962-966.
16. Gohlke H, Gohlke-Bärwolf C, Stürzenhofecker P et al. Improved graft patency with anticoagulant therapy after aortocoronary bypass surgery: A prospective, randomized study. Circulation, 1981; 64: II22-II27.
17. McEnany MT, Salzman EW, Mundth ED et al. The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts. J Thorac Cardiovasc Surg, 1982; 83: 81-89.